Acceleron Pharma Q2 2016 Financial Results

Acceleron Pharma's second quarter 2016 earnings presentation covering financial performance and operational highlights. The presentation includes updates on the company's pipeline of innovative therapeutics for serious and rare diseases, including development progress on compounds such as sotatercept, luspatercept, and ACE-083.